Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-04
1997-10-07
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 65, 549 59, 549 60, 549 77, 548527, 548540, 5483111, 5483117, 5483151, 548465, 546213, 5462814, 5462804, 544146, 544379, 544333, 514422, 514256, 514385, 514252, 514336, 514397, 514444, 514445, C07D33322, C07D40912, C07D41312, A61K 3138
Patent
active
056748906
ABSTRACT:
A compound of formula I ##STR1## in which Ar.sub.1 is naphthyl and phenyl, quinolyl or isoquinolyl optionally substituted; Ar.sub.2 is phenyl or thienyl optionally substituted; R.sub.1, R.sub.2 and R'.sub.2 are independently of each other H or (C.sub.1 -C.sub.4)alkyl or R.sub.1 represents a bond and N is covalently bonded to Ar.sub.2, and optionally R.sub.2 and R'.sub.2 form a double bond, or R.sub.1 or R.sub.2 is covalently bonded to Ar.sub.2 and represents a (C.sub.1 -C.sub.3 )alkylene; R.sub.3 and R.sub.4 are independently of each other H or (C.sub.1 -C.sub.4)alkyl or form, with the nitrogen atom to which they are attached pyrrolidine, ppiperidine, or hexahydroazepine; Z.sub.1 represents (C.sub.1 -C.sub.12)alkylene, optionally interrupted by a radical selected from the group consisting of (C.sub.5 -C.sub.7)cycloalkyl and phenyl or substituted with a radical selected from the group consisting of (C.sub.5 -C.sub.7)cycloalkyl and phenyl; Q.sub.1 is selected from the group consisting of methyl, amino, (C.sub.1 -C.sub.4)alkoxycarbonylamino, (C.sub.1 -C.sub.4)alkylamino, di(C.sub.1 -C.sub.4)-alkylamino, pyrrolidinyl, piperidino, morpholino, piperazinyl, 4-(C.sub.1 -C.sub.4)alkylpiperazinyl, amidino, (C.sub.1 -C.sub.4)-alkylamidino, guanidino, (C.sub.1 -C.sub.4)alkylguanidino, pyridyl, imidazolyl, pyrimidinyl, indolyl, hydroxy,(C.sub.1 phenyl substituted by a radical selected from the group consisting of Cl, F, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy and hydroxyle; Q.sub.2 is selected from the group consisting of H and (C.sub.1 -C.sub.4)alkyl; Q.sub.3 is selected from the group consisting of H and (C.sub.1 -C.sub.4)alkyl or Q.sub.1 and Q.sub.3 are attached to form a heterocycle and together represent (C.sub.2 -C.sub.3)alkylene, whereas Z.sub.1 represents a bond, in the form of pure enantiomer or mixture thereof in any proportions as well as its salt with acid.
REFERENCES:
patent: 4791102 (1988-12-01), Bernat et al.
patent: 5348976 (1994-09-01), Shibata et al.
M.C. Michel et al., "Neuropeptide Y and its antigonists", Drugs of the Future vol. 17, No. 1, 1992, pp. 39-45.
Christophe Bernard
Foulon Loic
Gal Claudine Serradeil-Le
Pellet Alain
Valette Gerard
Cross Laura R.
Richter Johann
Sanofi
LandOfFree
Compounds bearing sulphamoyl and amidino radicals, their prepara does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds bearing sulphamoyl and amidino radicals, their prepara, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds bearing sulphamoyl and amidino radicals, their prepara will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357695